Another COVID vaccine option? Here’s what we know about the Novavax shot that’s on the way

The Phase 3 trial results showed Novavax was 90.4% effective overall, 93% effective against predominately circulating variants and 100% effective in preventing hospitalization and deaths.
Source: https://www.bemidjipioneer.com